ȯÀÚ°¡ ´Ù¸¥ ȯÀÚ¿¡°Ô ÃßõÇÏ´Â, ÀÔ¼Ò¹®À¸·Î °ËÁõµÈ Âð ¸íÀÇ
±èÁØÃ¶ ±³¼ö´Â ¡®Âñ²ûÂñ²û ³ª¿À´Â ¼Òº¯Áٱ⠰íÄ¡·¯ ¿Ô´Ù°¡ ¼Ó±îÁö ¶Õ·È´Ù¡¯°í ȯÀÚµéÀÌ ¸»ÇÒ Á¤µµ·Î ȯÀÚ¿¡°Ô ¼³¸íÀ» Àß ÇÏ´Â ±³¼ö·Î À¯¸íÇÏ´Ù.
ȯÀÚ¿¡°Ô ¸Â´Â Ä¡·á¹ýÀ» °áÁ¤ÇÑ ÈÄ È¯ÀÚ¿Í º¸È£ÀÚ°¡ ÀÌÇØÇϱ⠽±°í È®½ÇÇÏ°Ô ¼³¸íÇØÁÖ´Ï °¡Á·°ú ÁöÀο¡°Ô Ãßõ¹Þ¾Æ ¿À´Â ȯÀÚ°¡ ¸¹´Ù. ƯÈ÷ Àü¸³¼±ºñ´ëÁõ ³²ÆíÀÌ ¿ä½Ç±Ý ¾Æ³» ȯÀÚ¸¦ µ¥¸®°í ¿À°Å³ª ±× ¹Ý´ë·Î ȯÀÚ¿´´ø ¾Æ³»°¡ ³²ÆíÀ» µ¥¸®°í ¿Í ÇÔ²² Ä¡·á¹Þ´Â ºÎºÎȯÀÚ°¡ À¯µ¶ ¸¹´Ù.
¶ÇÇÑ ²÷ÀÓ¾øÀÌ ¿¬±¸ÇÏ¿© ȯÀڵ鿡°Ô º¸´Ù ³ªÀº Ä¡·á¹æ¹ýÀ» ¸Å¼ø°£ Àû¿ëÇϰí ÀÖ´Ù. ÇØ¸¶´Ù ¹è´¢Àå¾Ö¿Í °ü·ÃµÈ ¿¬±¸³í¹®À» ¹ßÇ¥Çϰí ÀÖÀ¸¸ç, ƯÈ÷ Àü¸³¼±ºñ´ëÁõ°ú °ü·ÃµÈ °ú¹Î¼º¹æ±¤ÀÇ ¿øÀαԸí°ú ÁøÇà ¹æÁö¸¦ À§ÇÑ Áúȯ ¸ÞÄ¿´ÏÁò ¿¬±¸¿¡ ¸ÅÁøÇϰí ÀÖ´Ù. ÃÖ±Ù 5³â°£ International Journal of Urology World Journal of Urologyµî SCI±Þ Æ÷ÇÔ ¼¼°èÀûÀÎ ÇмúÁö¿¡ ¾à 40¿©ÆíÀÇ ³í¹®À» ±âÀçÇÏ´Â ¿¬±¸ÆÄ ±³¼ö´Ù.
Á¦ ¸ñ | Improvement of lower urinary tract dysfunction by a monoacylglycerol lipase inhibitor in mice with spinal cord injury | ||
---|---|---|---|
¹ßÇ¥³âµµ | 2024 | ¹ßÇ¥Áö | Neurourol Urodyn |
Á¦ ¸ñ | Novel pharmacotherapeutic avenues for bladder storage dysfunction in men. | ||
---|---|---|---|
¹ßÇ¥³âµµ | 2024 | ¹ßÇ¥Áö | Expert Opinion on Pharmacotherapy |
Á¦ ¸ñ | Outcomes of Artificial Urinary Sphincter Implantation in Patients with Detrusor Underactivity and Postprostatectomy Incontinence. | ||
---|---|---|---|
¹ßÇ¥³âµµ | 2023 | ¹ßÇ¥Áö | Urology Journal |
Á¦ ¸ñ | The incidence of testicular torsion and testicular salvage rate in Korea over 10 years: A nationwide population-based study | ||
---|---|---|---|
¹ßÇ¥³âµµ | 2022 | ¹ßÇ¥Áö | Investig Clin Urol. |
Á¦ ¸ñ | Efficacy and Safety of DA-8010, a Novel M3 Antagonist, in Patients With Overactive Bladder: A Randomized, Double-Blind Phase 2 Study | ||
---|---|---|---|
¹ßÇ¥³âµµ | 2022 | ¹ßÇ¥Áö | Int Neurourol J. |
Á¦ ¸ñ | Changes in transient receptor potential vanilloid 1 and transient receptor potential vanilloid 4 in patients with lower urinary tract dysfunction | ||
---|---|---|---|
¹ßÇ¥³âµµ | 2022 | ¹ßÇ¥Áö | Investig Clin Urol. |
Á¦ ¸ñ | Correlation Between Nitric Oxide and Urodynamics in Men With Bladder Outlet Obstruction | ||
---|---|---|---|
¹ßÇ¥³âµµ | 2022 | ¹ßÇ¥Áö | Int Neurourol J. |
Àü¸³¼±ºñ´ëÁõ°ú °ü·ÃµÈ °ú¹Î¼º¹æ±¤ÀÇ ¿øÀαԸí°ú ÁøÇà ¹æÁö¸¦ À§ÇÑ Áúȯ ¸ÞÄ¿´ÏÁò ¿¬±¸
ȯÀÚÀÇ »îÀÇ Áú ȸº¹
¹æ±¤ ÁúȯÀÌ ÇÏ·çÇÏ·çÀÇ ¹è´¢ Ȱµ¿°ú »ýȰ¹æ½Ä, ½Ä½À°ü µî°ú ¹ÐÁ¢ÇÑ °ü·ÃÀÌ ÀÖ´Â ¸¸Å Æò¼Ò »ýȰ ½À°üÀ» Àß °ü¸®ÇÏ´Â °Ô Áß¿äÇÏ´Ù. ¶ÇÇÑ ¹è´¢Àå¾Ö¿¡µµ ¿©·¯ Á¾·ù°¡ ÀÖ°í Áõ»ó¿¡ µû¶ó Ä¡·á¹æ¹ýÀÌ ´Ù¸£±â ¶§¹®¿¡ Àü¹®ÀÇ¿¡ ÀÇÇÑ Á¤È®ÇÑ Áø´Ü ÈÄ ÀûÀýÇÑ Ä¡·á¸¦ ½ÃÇàÇØ¾ß ÇÑ´Ù.
°¡Å縯´ëÇб³ ºÎõ¼º¸ðº´¿øÀº ºÎõÁö¿ª ÃÖÃÊÀÇ ´ëÇк´¿øÀ¸·Î 1958³â °³¿ø ÀÌ·¡ ÃÖ»óÀÇ ÀǷἺñ½º¸¦ Á¦°øÇϸç Áö¿ª»çȸ ÀÇ·á¹ßÀü°ú °Ç°ÁõÁø¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù.
°æÀÎÁö¿ª ÃÖÃÊ ½ÅÀåÀ̽İú °ñ¼öÀÌ½Ä ¼º°ø, Àå±âÀ̽ĵî·Ï ±â°ü ¹× Àå±âÀ̽ÄÀÇ·á±â°ü
(°£, ½ÅÀå, °¢¸·) ÁöÁ¤, ¾Æ½Ã¾Æ ÃÖÃÊ ³úÇ÷°ü³» ½ºÅÙÆ® Ç÷°ü ¼ºÇü¼ú ¼º°ø, ±¹³» ÃÖÃÊ ¡®ÇùÁø½Ã½ºÅÛ¡¯ ±¸Ãà µî ´ëÇѹα¹À» ³Ñ¾î ¾Æ½Ã¾Æ¸¦ ´ëÇ¥ÇÏ´Â ´ëÇк´¿øÀ¸·Î È®°íÈ÷ ÀÚ¸®¸Å±èÇϸç Ä¡À¯ÀÚÀ̽Š¿¹¼ö±×¸®½ºµµÀÇ »ç¶ûÀ» ½ÇõÇϰí ÀÖ½À´Ï´Ù.
°æ±âµµ ºÎõ½Ã ¿ø¹Ì±¸ ¼Ò»ç·Î 327(¼Ò»çµ¿)